CM
Castleark Management Portfolio holdings
AUM
$3.33B
1-Year Return
37.9%
This Quarter Return
+15.59%
1 Year Return
+37.9%
3 Year Return
+222.09%
5 Year Return
+481.09%
10 Year Return
+2,703.89%
AUM
$2.21B
AUM Growth
+$172M
(+8.5%)
Cap. Flow
-$16.2M
Cap. Flow
% of AUM
-0.73%
Top 10 Holdings %
Top 10 Hldgs %
35.68%
Holding
326
New
54
Increased
55
Reduced
104
Closed
52
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$44.2M |
| 2 |
Microsoft
MSFT
|
$38.4M |
| 3 |
Amazon
AMZN
|
$27.8M |
| 4 |
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
$20.8M |
| 5 |
Stryker
SYK
|
$13.7M |
Top Sells
| 1 |
Tesla
TSLA
|
$39.7M |
| 2 |
Ulta Beauty
ULTA
|
$38.5M |
| 3 |
PayPal
PYPL
|
$30.6M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
$26.1M |
| 5 |
UnitedHealth
UNH
|
$23.6M |
Sector Composition
| 1 | Technology | 30.84% |
| 2 | Healthcare | 15.53% |
| 3 | Consumer Discretionary | 12.94% |
| 4 | Industrials | 9.32% |
| 5 | Financials | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
WIX.com
WIX
$8.19B
| $4.25M | 0.19% |
54,340
-13,180
| -20% | -$1.03M |
|
127
NeoGenomics
NEO
$1.04B
| $4.22M | 0.19% |
262,507
+29,140
| +12% | +$468K |
|
128
Tenable Holdings
TENB
$3.68B
| $4.21M | 0.19% |
96,710
-870
| -0.9% | -$37.9K |
|
|
ALTR
129
DELISTED
Altair Engineering Inc. Class A Common Stock
ALTR
| $4.12M | 0.19% |
54,380
-490
| -0.9% | -$37.2K |
|
130
Masco
MAS
$15.5B
| $4.12M | 0.19% |
71,800
| – | – |
|
|
SWAV
131
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $3.9M | 0.18% |
+13,680
| New | +$3.9M |
|
132
Shoals Technologies Group
SHLS
$1.2B
| $3.89M | 0.18% |
152,140
+147,860
| +3,455% | +$3.78M |
|
133
Corsair Gaming
CRSR
$950M
| $3.89M | 0.18% |
+219,020
| New | +$3.89M |
|
134
SI-BONE Inc
SIBN
$705M
| $3.85M | 0.17% |
+142,762
| New | +$3.85M |
|
135
Digi International
DGII
$1.27B
| $3.83M | 0.17% |
97,110
-59,680
| -38% | -$2.35M |
|
136
Apellis Pharmaceuticals
APLS
$3.62B
| $3.72M | 0.17% |
+40,820
| New | +$3.72M |
|
137
Xenon Pharmaceuticals
XENE
$2.98B
| $3.64M | 0.16% |
94,490
+16,750
| +22% | +$645K |
|
138
Perion Network
PERI
$411M
| $3.55M | 0.16% |
+115,860
| New | +$3.55M |
|
139
Vaxcyte
PCVX
$4.17B
| $3.45M | 0.16% |
+69,000
| New | +$3.45M |
|
140
10x Genomics
TXG
$1.69B
| $3.42M | 0.16% |
+61,310
| New | +$3.42M |
|
141
Belden
BDC
$5.13B
| $3.37M | 0.15% |
35,200
-26,610
| -43% | -$2.55M |
|
142
Western Midstream Partners
WES
$14.7B
| $3.36M | 0.15% |
126,800
-59,420
| -32% | -$1.58M |
|
143
Civitas Resources
CIVI
$3.29B
| $3.35M | 0.15% |
+48,230
| New | +$3.35M |
|
144
Generac Holdings
GNRC
$10.5B
| $3.32M | 0.15% |
+22,280
| New | +$3.32M |
|
145
Veracyte
VCYT
$2.48B
| $3.27M | 0.15% |
128,460
+17,560
| +16% | +$447K |
|
146
Churchill Downs
CHDN
$7.15B
| $3.26M | 0.15% |
23,430
+1,190
| +5% | +$166K |
|
147
Allison Transmission
ALSN
$7.46B
| $3.25M | 0.15% |
57,630
-20,160
| -26% | -$1.14M |
|
|
RVNC
148
DELISTED
Revance Therapeutics, Inc.
RVNC
| $3.18M | 0.14% |
125,727
+23,140
| +23% | +$586K |
|
149
Treace Medical Concepts
TMCI
$453M
| $3.17M | 0.14% |
123,780
-5,470
| -4% | -$140K |
|
150
Arrowhead Research
ARWR
$3.87B
| $3.06M | 0.14% |
+85,690
| New | +$3.06M |
|